Home Search
- search results
If you're not happy with the results, please do another search
Pharma: can the middle hold?
Mid-size companies need to think small – before the big ones do. Here, the McKinsey Quarterly examines the way in which mid-size pharmaceutical companies can hold off consolidation, retain their market share and build on their strengths for a bright future in the industry.
Continental Europe: April 2001
Phoenix breaks free from CSFB, Easdaq and Nasdaq to merge, Italy's first fund of funds, European private equity figures, Germany's M&A boom...
UK and Ireland: April 2001
IPO activity slows, large buy-out market alive and well, Barings and F&C Ventures spinning out, local authorities get into private equity...
Africa and the Middle East: April 2001
South African private equity growing, despite troubles and Israel to benefit from biotech boom...
North America: April 2001
Insight and Geocapital return funds, Hummer Winblad apologises, IPOs stagnant...
Trends: April 2001
VCs appear in top 100, boom in corporate venturing, fund raising gets tough...
Funds: April 2001
IDG comes to Europe, Illuminator, Electra raise first funds, Penta and Atlas close, Duke Street launches new fund...
Accessing venture capital and private equity through fund of funds
Investing via a fund of funds can give you access to the best funds and ensure that you have a diversified private equity portfolio. Wilshire Associates outlines the benefits of fund of funds.
Asia’s second venture wave
Venture capital is returning to Asia, attracted by the large pool of technical talent and entrepreneurship – but also by more reasonable valuations. Here the Far Eastern Economic Review looks at the reasons behind the return.
The Israeli high-tech industry
With over 80 venture capital firms operating in Israel and over $6.5bn under management in Israeli technology funds, this is an industry that investors should keep a close eye on.